|
1
|
Babjuk M, Oosterlinck W, Sylvester R,
Kaasinen E, Böhle A, Palou-Redorta J and Rouprêt M; Asociación
Europea de Urología, : EAU guidelines on non-muscle-invasive
urothelial carcinoma of the bladder, the 2011 update. Actas Urol
Esp. 36:389–402. 2012.(In Spanish). View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stenzl A, Cowan NC, De Santis M, Jakse G,
Kuczyk MA, Merseburger AS, Ribal MJ, Sherif A and Witjes JA: The
updated EAU guidelines on muscle-invasive and metastatic bladder
cancer. Eur Urol. 55:815–825. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
DeGraff DJ, Clark PE, Cates JM, Yamashita
H, Robinson VL, Yu X, Smolkin ME, Chang SS, Cookson MS, Herrick MK,
et al: Loss of the urothelial differentiation marker FOXA1 is
associated with high grade, late stage bladder cancer and increased
tumor proliferation. PLoS One. 7:e366692012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Greer P: Closing in on the biological
functions of Fps⁄Fes and Fer. Nat Rev Mol Cell Biol. 3:278–289.
2002. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ahn J, Truesdell P, Meens J, Kadish C,
Yang X, Boag AH and Craig AW: Fer protein-tyrosine kinase promotes
lung adenocarcinoma cell invasion and tumor metastasis. Mol Cancer
Res. 11:952–963. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li H, Ren Z, Kang X, Zhang L, Li X, Wang
Y, Xue T, Shen Y and Liu Y: Identification of
tyrosine-phosphorylated proteins associated with metastasis and
functional analysis of FER in human hepatocellular carcinoma cells.
BMC Cancer. 9:3662009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rocha J, Zouanat FZ, Zoubeidi A, Hamel L,
Benidir T, Scarlata E, Brimo F, Aprikian A and Chevalier S: The Fer
tyrosine kinase acts as a downstream interleukin-6 effector of
androgen receptor activation in prostate cancer. Mol Cell
Endocrinol. 381:140–149. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Albeck JG and Brugge JS: Uncovering a
tumor suppressor for triple-negative breast cancers. Cell.
144:638–640. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hu X, Zhang Z, Liang Z, Xie D, Zhang T, Yu
D and Zhong C: Downregulation of feline sarcoma-related protein
inhibits cell migration, invasion and epithelial-mesenchymal
transition via the ERK/AP-1 pathway in bladder urothelial cell
carcinoma. Oncol Lett. 13:686–694. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Allard P, Zoubeidi A, Nguyen LT, Tessier
S, Tanguay S, Chevrette M, Aprikian A and Chevalier S: Links
between Fer tyrosine kinase expression levels and prostate cell
proliferation. Mol Cell Endocrinol. 159:63–77. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pasder O, Shpungin S, Salem Y, Makovsky A,
Vilchick S, Michaeli S, Malovani H and Nir U: Downregulation of Fer
induces PP1 activation and cell-cycle arrest in malignant cells.
Oncogene. 25:4194–4206. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xu G, Craig AW, Greer P, Miller M,
Anastasiadis PZ, Lilien J and Balsamo J: Continuous association of
cadherin with beta-catenin requires the non-receptor
tyrosine-kinase Fer. J Cell Sci. 117:3207–3219. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sangrar W, Gao Y, Scott M, Truesdell P and
Greer PA: Fer-mediated cortactin phosphorylation is associated with
efficient fibroblast migration and is dependent on reactive oxygen
species generation during integrin-mediated cell adhesion. Mol Cell
Biol. 27:6140–6152. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Burlacu A: Regulation of apoptosis by
Bcl-2 family proteins. J Cell Mol Med. 7:249–257. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Alnemri ES, Livingston DJ, Nicholson DW,
Salvesen G, Thornberry NA, Wong WW and Yuan J: Human ICE/CED-3
protease nomenclature. Cell. 87:1711996. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cuadrado A and Nebreda AR: Mechanisms and
functions of p38 MAPK signalling. Biochem J. 429:403–417. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Letwin K, Yee SP and Pawson T: Novel
protein-tyrosine kinase cDNAs related to fps/fes and eph cloned
using anti-phosphotyrosine antibody. Oncogene. 3:621–627.
1988.PubMed/NCBI
|
|
19
|
Hao QL, Heisterkamp N and Groffen J:
Isolation and sequence analysis of a novel human tyrosine kinase
gene. Mol Cell Biol. 9:1587–1593. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Oneyama C, Yoshikawa Y, Ninomiya Y, Iino
T, Tsukita S and Okada M: Fer tyrosine kinase oligomer mediates and
amplifies Src-induced tumor progression. Oncogene. 35:501–512.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang Y, Wang T, Han Y, Wu H, Zhao W, Tong
D, Wei L, Zhong Z, An R and Wang Y: Reduced ING4 Expression Is
Associated with the Malignancy of Human Bladder. Urol Int.
94:464–471. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kelekar A and Thompson CB: Bcl-2-family
proteins: The role of the BH3 domain in apoptosis. Trends Cell
Biol. 8:324–330. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Simpson NH, Singh RP, Emery AN and
Al-Rubeai M: Bcl-2 over-expression reduces growth rate and prolongs
G1 phase in continuous chemostat cultures of hybridoma cells.
Biotechnol Bioeng. 64:174–186. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cleary ML, Smith SD and Sklar J: Cloning
and structural analysis of cDNAs for bcl-2 and a hybrid
bcl-2/immunoglobulin transcript resulting from the t(14;18)
translocation. Cell. 47:19–28. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang L, Wu X, Wang D, Luo C and Chen L:
Renal carcinoma cell-derived exosomes induce human immortalized
line of Jurkat T lymphocyte apoptosis in vitro. Urol Int.
91:363–369. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Senis YA, Sangrar W, Zirngibl RA, Craig
AW, Lee DH and Greer PA: Fps/Fes and Fer non-receptor
protein-tyrosine kinases regulate collagen- and ADP-induced
platelet aggregation. J Thromb Haemost. 1:1062–1070. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Craig AW and Greer PA: Fer kinase is
required for sustained p38 kinase activation and maximal chemotaxis
of activated mast cells. Mol Cell Biol. 22:6363–6374. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wada T and Penninger JM: Mitogen-activated
protein kinases in apoptosis regulation. Oncogene. 23:2838–2849.
2004. View Article : Google Scholar : PubMed/NCBI
|
